InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
T+90 hit rate
0%
T+90 mean return
-11.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Peters Richard, Président et CEO. Insider active across 3 companies, notably Aprea Therapeutics, Inc.. Cumulatively, 15 filings have been published. Split: 0 buy · 4 sells. Total volume traded: €55k. History available since 30 June 2021. The latest transaction was disclosed on 20 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations15 total
3,135 sharesCommon StockSEC:0001104659-26-075283:0
1,045 shares0Common StockSEC:0001104659-24-073943:0
500 shares0Common StockSEC:0001104659-23-095018:0
1,931 shares@ US$1.86100.0% of flowCommon StockSEC:0001209191-22-062282:0
10,890 shares@ US$1.691312.6% of flowCommon StockSEC:0000899243-22-037790:0
5,995 shares0Common StockSEC:0001104659-22-084770:0
4,584 shares@ US$1.84916.0% of flowCommon StockSEC:0000899243-22-025399:0
10,206 shares@ US$1.194610.1% of flowCommon StockSEC:0000899243-22-021283:0
10,715 shares@ US$1.845516.0% of flowCommon StockSEC:0000899243-22-012782:0
70,000 shares0Common StockSEC:0000899243-21-046760
70,000 shares0Common StockSEC:0000899243-21-046760:0
4,441 shares@ US$11.1137.0% of flowCommon StockSEC:0000899243-21-027794:0
4,441 shares@ US$11.1130.1% of flowCommon StockSEC:0000899243-21-027794
4,610 shares0Common StockSEC:0001567619-21-012873:0
4,610 shares0Common StockSEC:0001567619-21-012873
15 of 15 declarations
About Peters Richard
Richard Peters is President and CEO at Aprea Therapeutics, Inc. and Yumanity Therapeutics, Inc. He is responsible for the overall direction and strategy of the companies. His role is essential in guiding initiatives and ensuring growth.
